Baltic
Dry Index. 3346 -203 Brent Crude 77.21
Spot Gold 2026 US 2 Year Yield 4.64 -0.07
Q. How can you
tell when the US NSA is monitoring your computer?
A. The power is on and you’re connected to the
internet.
In the stock casinos, more final 2023 exit rally. Bad things will happen fast in 2024.
Look away from that falling oil price and
inverting US Treasury yield curve now.
Asia markets
rebound across the region from Tuesday’s broad sell-off
UPDATED WED, DEC 6 2023 12:41 AM
EST
Asia-Pacific
markets rebounded across the region, following a broad sell-off on Tuesday.
Investors assessed
Australia’s third-quarter GDP numbers, as well as the Reuters Tankan survey for
Japan in December, which showed improving business sentiment among large
Japanese manufacturers.
The Tankan survey,
done by the Bank of Japan quarterly, measures economic conditions in Japan and
the survey results are considered a key economic indicator.
The Reuters monthly
poll is considered to be a leading indicator of the BOJ’s official survey.
In Australia, the S&P/ASX 200 rose
1.65%, closing at 7,178.4 and at its highest level since September 19.
The country’s economy expanded
2.1% year-on-year in the third quarter, beating expectations from economists
polled by Reuters.
Japan’s Nikkei 225 popped
1.97%, leading gains among major Asian indexes, while the Topix advanced 1.86%.
South Korea’s Kospi inched
up 0.37%, while the small-cap Kosdaq climbed 1.02%.
Hong Kong’s Hang Seng index rebounded
from a one-year low to climb 1.35%, while the mainland Chinese CSI 300 index
posted a 0.37% gain, after hitting fresh four-year lows on Tuesday.
Overnight in the U.S., the Dow Jones Industrial Average and
the S&P 500 slid
on Tuesday as a recent rally on Wall Street lost steam.
The 30-stock Dow slid 0.22%,
while the S&P 500 inched lower by 0.06%. In contrast, the Nasdaq Composite gained
0.31% to end at 14,229.91 as technology shares outperformed.
Asia stock markets
today: Live updates, Reuters Tankan, Australia GDP (cnbc.com)
China blue-chip
stocks hit 5-year lows, yuan eases after Moody's move
December 6,
20235:12 AM GMT
SHANGHAI, Dec 6
(Reuters) - China's blue-chip stocks slumped to an almost five-year trough on
Wednesday while the yuan currency extended losses, as markets grappled with
Moody's cut to China's credit outlook at a time of growing worries about the
economy's stuttering recovery.
The
ratings agency issued a downgrade warning on China's
credit rating on Tuesday, saying costs to bail out local governments and state
firms and control its property crisis would weigh on the world's second-largest
economy.
China
stocks opened down with the CSI300 Index (.CSI300) touching its lowest
level since Feb. 2019, before recouping earlier losses. It was up 0.2% by
midday, while the Shanghai Composite Index (.SSEC) was down 0.1%.
Chinese markets
have had a torrid time this year as a shaky economic recovery and a deepening
property crisis have added to geopolitical challenges, including protracted
Sino-U.S. tensions over tech and trade.
The CSI300 Index
has tumbled 12.2% so far this year and is set to record one of the worst
performer in the region.
The
Hang Seng Index (.HSI),
meanwhile, rebounded roughly 0.7% in morning trade, with tech shares (.HSTECH) leading gains.
"The CSI300
index was hit the hardest in terms of valuation, as the index gets more
allocations from foreign investors. Adding the impact of Moody's cut, the index
may find a bottom and rebound soon," said Pang Xichun, research director
at Nanjing RiskHunt Investment Management Co.
Foreign capital
recorded a net inflow via the northbound trading link as of midday, after three
consecutive sessions of outflows.
"Moody's
decision to downgrade its outlook on China's debt is the latest link in a long
string of recent disappointments for investors in Chinese equities," said
Yasser El-Shimy, investment analyst at The Motley Fool.
China's economic
recovery has shown signs of losing steam quickly after an initial burst in
consumer and business activity at the start of the year, weighed down by an
ailing housing market, local government debt risks and slow global growth.
More
China
blue-chip stocks hit 5-year lows, yuan eases after Moody's move | Reuters
Stock
futures rise Tuesday night after the S&P 500, Dow slip for a second day:
Live updates
UPDATED TUE, DEC 5 2023 8:24 PM
EST
U.S. stock futures climbed Tuesday night after
the S&P 500 and the Dow Jones Industrial Average slid for a second day.
Futures
tied to the 30-stock Dow rose
50 points, or 0.1%. S&P 500 futures
and Nasdaq 100 futures added
0.2% and 0.4%, respectively.
Cloud company Box was
a notable loser in after-hours action, tumbling 12% after reporting
third-quarter results that came in below analyst expectations. MongoDB slipped
5%, even as the company beat analysts’ estimates. On the other hand,
homebuilder stock Toll Brothers gained
nearly 2% after exceeding expectations on the top and bottom lines.
The moves came after a trading
session where both the Dow and
the S&P 500 closed
lower for the second day in a row, dropping 0.2% and 0.06%, respectively. The Nasdaq Composite gained
0.3% to end the day.
Despite these losses, the past
five weeks of consecutive gains means that all three stock indexes are still on
track to end the quarter and year with big gains.
Looking past this rally, come the
new year Wolfe Research chief investment strategist Chris Senyek sees disappointment
ahead for investors. In his base case scenario, Senyek sees the
S&P 500 dropping 8% by the end of 2024.
“We think the lagged impacts of
the Fed rate hikes are going to really start to hit the economy in the first
half of next year,” he said on CNBC’s “Closing Bell: Overtime.”
As inflation falls, companies
will lose their pricing power because they lose their ability to pass prices
through the consumers, he said. Senyek also expects that higher risk aversion
and slower earnings growth will put additional pressure on stocks next year.
Stock
market today: Live updates (cnbc.com)
European markets set to regain positive momentum
and rebound at the open
UPDATED WED, DEC 6 2023 12:30 AM
EST
European markets are heading for a positive open
Wednesday, rebounding from mixed trade seen earlier in the week.
Positive momentum was seen
elsewhere overnight. Asia-Pacific markets rebounded
across the region, following a broad sell-off on Tuesday. Meanwhile,
U.S. stock futures climbed overnight after the S&P 500 and
the Dow Jones Industrial Average slid for a second day Tuesday.
European
markets live updates: stocks, news, data and earnings (cnbc.com)
Next, who really needs a weaponised US fiat
dollar? I’m not sure switching from a debtor fiat dollar to a creditor fiat
Yuan makes any sense, but in a world with people prepared to buy worthless
Bitcoin for 44,000 dodgy US dollars, nothing much makes financial sense in the now
ending of the Great Nixonian Error of Fiat Money.
Against
the odds, China’s push to internationalise its currency is making gains
Geopolitical
concerns help support the use of the renminbi despite weak foreign investment
trends
December 6, 2023
It has been an extraordinary year for the renminbi. On the one hand, it has clearly disappointed investors, who were expecting the currency to appreciate as the Chinese economy moved out of zero-Covid policies at the end of 2022.
Instead, after a short respite, it depreciated about 8.5 per cent against the US currency from January lows until it found a floor at about 7.30 renminbi per dollar. The trend reflected the stubborn weakness of the Chinese economy and the large capital outflows. More recently the renminbi has appreciated but that is in line with other currencies as the US Federal Reserve shifted to a less hawkish tone on interest rates.
However, that very same weak renminbi has achieved something quite impressive in 2023: a fast increase in its cross-border use. Since China started to push for the internationalisation of its currency in 2004, its share in global payments largely remained stagnant. But this year its share went from 1.9 per cent in January 2023 to 3.6 per cent in October.
Such a share remains low compared with the dollar (47.25 per cent) and the euro (23.36 per cent). But the growth could be pointing to a change. And the People’s Bank of China has reported a steep increase in renminbi-denominated current account transactions. Nearly 30 per cent of the trade in goods and services in and out of the country was settled in the currency.
When looking at the main drivers for this change, several issues stand out. Firstly, China seems increasingly keen to settle its trade in renminbi. The reasons behind this seem to go beyond reducing hedging costs, which have always existed. It is also, of course, driven by geopolitical concerns.
Reducing the dependence on the US dollar or other G7 currencies has become more important for China, given the step-up in western sanctions on Russia after it invaded Ukraine in 2022 and tensions with the US over Taiwan. These sanctions also seem to have been a catalyst for other countries to accept the renminbi for trade settlements. The fact that China had its own international payment system (Cips) ready to be used when western sanctions hit Russia has undoubtedly helped. Some renminbi international payments settled through Cips, do not use the Swift interbank messaging system, which makes them very difficult to be traced. This also means that the share of renminbi for global cross-border transactions might be underestimated.
Beyond the establishment of
Cips, Chinese authorities have introduced other important instruments to
support renminbi internationalisation, such as bilateral currency swaps between
the PBoC and more than 30 central banks. These swap lines used to sit idle in
host central banks but they are now starting to be withdrawn given some
emerging countries’ growing financial needs. A notable example is Argentina,
which has already withdrawn the equivalent of $1bn in renminbi from its swap
line to cover repayments to the IMF. Chinese authorities have also stepped up
efforts to increase renminbi liquidity offshore by setting up clearing centres
for the currency.
More
Against the odds, China’s push to internationalise its currency is making gains (ft.com)
Finally, worrying news about artificial
intelligence. The intelligence may be more artificial than intelligent.
Free ChatGPT
may incorrectly answer drug questions, study says
PUBLISHED TUE, DEC 5 2023 12:01
AM EST
The free version of ChatGPT may
provide inaccurate or incomplete responses — or no answer at all — to questions
related to medications, which could potentially endanger patients who use OpenAI’s viral chatbot,
a new study released Tuesday suggests.
Pharmacists at Long
Island University who posed 39
questions to the free ChatGPT in
May deemed that only 10 of the chatbot’s responses were “satisfactory” based on
criteria they established. ChatGPT’s responses to the 29 other drug-related
questions did not directly address the question asked, or were inaccurate,
incomplete or both, the study said.
The study indicates that patients and health-care
professionals should be cautious about relying on ChatGPT for drug information
and verify any of the responses from the chatbot with trusted sources,
according to lead author Sara Grossman, an associate professor of pharmacy
practice at LIU. For patients, that can be their doctor or a
government-based medication information website such as the National Institutes
of Health’s MedlinePlus, she
said.
Grossman said the research did not require any
funding.
ChatGPT was widely seen as the fastest-growing
consumer internet app of all time following its launch roughly
a year ago, which ushered in a breakout year for artificial intelligence. But
along the way, the chatbot has also raised concerns about issues
including fraud, intellectual property, discrimination and misinformation.
Several studies have highlighted similar instances of erroneous
responses from ChatGPT, and the Federal Trade Commission in July opened an investigation into the chatbot’s accuracy and consumer
protections.
In October, ChatGPT drew around 1.7 billion visits worldwide,
according to one analysis. There is no data on how many users ask medical
questions of the chatbot.
Notably, the free version of ChatGPT is limited to using data sets through September 2021 — meaning
it could lack significant information in the rapidly changing medical
landscape. It’s unclear how accurately the paid versions of ChatGPT, which
began to use real-time internet browsing earlier this year, can now answer medication-related
questions.
Grossman acknowledged there’s a chance that a paid
version of ChatGPT would have produced better study results. But she said that
the research focused on the free version of the chatbot to replicate what more
of the general population uses and can access.
More
Free ChatGPT may incorrectly answer drug questions, study says (cnbc.com)
Natural stupidity!
Global Inflation/Stagflation/Recession
Watch.
Given
our Magic Money Tree central banksters and our spendthrift politicians,
inflation now needs an entire section of its own.
Moody’s cut
China’s credit outlook to negative on rising debt risks
PUBLISHED TUE, DEC 5 2023 4:48 AM
EST
Ratings agency
Moody’s downgraded its outlook on China’s government credit ratings to negative
from stable, expecting Beijing’s support and possible bailouts for distressed
local governments and state-owned enterprises to diminish China’s fiscal,
economic and institutional strength.
Moody’s though
retained China’s “A1” long-term rating on the country’s sovereign bonds, while
expecting China annual GDP growth to slow to 4% in 2024 and 2025 and average
3.8% from 2026 to 2030.
Structural factors
including weak demographics will drive a decline to 3.5% by 2030, it said.
The move underscores concerns over rising debt
levels and the impact on broader growth in the world’s second-largest economy
as Beijing resorts to fiscal stimulus to support local governments and contain
the spiraling debt crisis among the country’s property developers.
“The outlook change also reflects the increased
risks related to structurally and persistently lower medium-term economic
growth and the ongoing downsizing of the property sector,” Moody’s said in
a statement issued Dec. 5.
“These trends underscore the increasing risks
related to policy effectiveness, including the challenge to design and
implement policies that support economic rebalancing while preventing moral
hazard and containing the impact on the sovereign’s balance sheet,” Moody’s
added.
China credit default swaps (the cost of insuring
against a government default) rose 4 basis points from Monday’s closing level,
according to Reuters data.
Beijing
disappointment
China’s Finance Ministry expressed its
disappointment with Moody’s downgrade decision.
“Moody’s concerns about China’s economic growth
prospects and fiscal sustainability are unnecessary,” the ministry said in a statement Tuesday.
More
Moody's cut China's credit outlook to negative on rising debt risks (cnbc.com)
Covid-19 Corner
This
section will continue until it becomes unneeded.
Vaccinated People
More Likely to Suffer Blood Disorders, Ear Disease: Studies
People
who received COVID-19 vaccines at higher risk of a range of conditions, South
Korean researchers find.
11/28/2023 Updated: 12/4/2023
People who
received a COVID-19 vaccine were more likely to suffer a range of conditions,
including a lack of blood cells being produced and ear disease, according to
new studies.
Researchers in
South Korea analyzed data from the Korean National Health Insurance Service to
examine whether vaccinated or unvaccinated people had experienced higher rates
of dozens of adverse events, including menstrual disorder, ear disease, and
aplastic anemia.
They found that
vaccination increased the risk of many of the adverse events or health
conditions.
In one study, for
instance, they found that the incidence rates of 13 immune-related nonfatal
adverse events (irAEs) were higher among the vaccinated. The nonfatal problems
included menstrual disorder, bruising, tinnitus, inner ear disease, middle ear
disease, and other ear disease.
"Vaccination
significantly increased the risks of non-fatal irAEs," Dr. Eun Mi Chun,
with Ewha Womans University's School of Medicine, and the co-authors wrote.
The researchers
looked at records from people aged 20 and up. People were counted as vaccinated
if they received their second dose or completed a primary series before Sept.
30, 2021. People were counted as unvaccinated if they received no doses. People
were excluded if they received one dose or had any of the conditions already.
The vaccinated
group included 1.4 million people, compared to 289,576 in the unvaccinated
group. The latter skewed younger, with fewer comorbidities, one factor that
potentially affected the results.
Researchers
measured cumulative incidence rates of the adverse events, which were picked
because the doctors felt that nonfatal immune-related problems after COVID-19
vaccination "have yet to be comprehensively elucidated."
The rates were
measured by examining diagnoses among the two cohorts.
More
Vaccinated People More Likely to Suffer Blood Disorders, Ear Disease: Studies | The Epoch Times
Technology
Update.
With events happening fast in the
development of solar power and graphene, among other things, I’ve added this
section. Updates as they get reported.
Dec 05, 2023 |
||||||||||||
Tiny electromagnets made of graphene
(Nanowerk
News) An international research team has now added another facet
to graphene's diverse properties with experiments at the Helmholtz-Zentrum
Dresden-Rossendorf (HZDR): The experts, led by the University of
Duisburg-Essen (UDE), fired short terahertz pulses at micrometer-sized discs
of graphene, which
briefly turned these minuscule objects into surprisingly strong magnets. This
discovery may prove useful for developing future magnetic switches and
storage devices. |
||||||||||||
The working group presents its study in the scientific online
journal Nature
Communications ("Strong
transient magnetic fields induced by THz-driven plasmons in graphene
disks")
Thanks to computer autocorrect, 1 in 5
children will be getting a visit from Satan this Christmas. |
No comments:
Post a Comment